Renal Parenchymal Thickness in Patients with Systemic Sclerosis Is Related to Intrarenal Hemodynamic Variables and Raynaud Renal Phenomenon

REFERENCES

1. 1.↵
   1. Wang X,
   2. Vrtiska TJ,
   3. Avula RT,
   4. Walters LR,
   5. Chakkera HA,
   6. Kremers WK,
   7. et al.

   Age, kidney function, and risk factors associate differently with cortical and medullary volumes of the kidney. Kidney Int 2014;85:677–85.

   OpenUrlCrossRefPubMed
2. 2.↵
   1. Takata T,
   2. Koda M,
   3. Sugihara T,
   4. Sugihara S,
   5. Okamoto T,
   6. Miyoshi K,
   7. et al.

   Left renal cortical thickness measured by ultrasound can predict early progression of chronic kidney disease. Nephron 2016;132:25–32.

   OpenUrl
3. 3.↵
   1. Petrucci I,
   2. Clementi A,
   3. Sessa C,
   4. Torrisi I,
   5. Meola M

   . Ultrasound and color Doppler applications in chronic kidney disease. J Nephrol 2018;31:863–79.

   OpenUrl
4. 4.↵
   1. Boddi M

   . Renal ultrasound (and Doppler sonography) in hypertension: an update. Adv Exp Med Biol 2017;956:191–208.

   OpenUrl
5. 5.↵
   1. Rosato E,
   2. Gigante A,
   3. Barbano B,
   4. Gasperini ML,
   5. Cianci R,
   6. Muscaritoli M

   . Prognostic factors of renal involvement in systemic sclerosis. Kidney Blood Press Res 2018;43:682–9.

   OpenUrl
6. 6.↵
   1. Rosato E,
   2. Gigante A,
   3. Barbano B,
   4. Cianci R,
   5. Molinaro I,
   6. Rossi C,
   7. et al.

   Intrarenal hemodynamic parameters correlate with glomerular filtration rate and digital microvascular damage in patients with systemic sclerosis. Semin Arthritis Rheum 2012;41:815–2.

   OpenUrlCrossRefPubMed
7. 7.↵
   1. Rosato E,
   2. Navarini L,
   3. Gigante A,
   4. Cianci R,
   5. Margiotta D,
   6. Barbano B,
   7. et al.

   Intrarenal arterial stiffness is increased in systemic sclerosis patients with anti-ribonucleic acid polymerase III antibodies. Rheumatology 2017;56:1039–41.

   OpenUrl
8. 8.↵
   1. Rosato E,
   2. Gigante A,
   3. Barbano B,
   4. Molinaro I,
   5. Cianci R,
   6. Salsano F

   . Doppler indices of intrarenal arterial stiffness are useful in monitoring scleroderma renal crisis. Scand J Rheumatol 2013;42:80–1.

   OpenUrlCrossRefPubMed
9. 9.↵
   1. van den Hoogen F,
   2. Khanna D,
   3. Fransen J,
   4. Johnson SR,
   5. Baron M,
   6. Tyndall A,
   7. et al.

   2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis 2013;72:1747–55.

   OpenUrlAbstract/FREE Full Text
10. 10.↵
    1. Levey AS,
    2. Stevens LA,
    3. Schmid CH,
    4. Zhang YL,
    5. Castro AF,
    6. Feldman HI,
    7. et al.

    CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate. Ann Intern Med 2009;150:604–12.

    OpenUrlCrossRefPubMed
11. 11.↵
    1. Gigante A,
    2. Rosato E,
    3. Massa R,
    4. Rossi C,
    5. Barbano B,
    6. Cianci R,
    7. et al.

    Evaluation of Chronic Kidney Disease Epidemiology Collaboration equation to estimate glomerular filtration rate in scleroderma patients. Rheumatology 2012;51:1426–31.

    OpenUrlCrossRefPubMed
12. 12.↵
    1. LeRoy EC,
    2. Black C,
    3. Fleischmajer R,
    4. Jablonska S,
    5. Krieg T,
    6. Medsger TA Jr,
    7. et al.

    Scleroderma (systemic sclerosis): classification, subsets, and pathogenesis. J Rheumatol 1988;15:202–5.

    OpenUrlPubMed
13. 13.↵
    1. Valentini G,
    2. Iudici M,
    3. Walker UA,
    4. Jaeger VK,
    5. Baron M,
    6. Carreira P,
    7. et al.

    The European Scleroderma Trials and Research group (EUSTAR) task force for the development of revised activity criteria for systemic sclerosis: derivation and validation of a preliminarily revised EUSTAR activity index. Ann Rheum Dis 2017;76:270–6.

    OpenUrlAbstract/FREE Full Text
14. 14.↵
    1. Medsger TA Jr,
    2. Silman AJ,
    3. Steen VD,
    4. Black CM,
    5. Akesso A,
    6. Bacon PA,
    7. et al.

    A disease severity scale for systemic sclerosis: development and testing. J Rheumatol 1999;26:2159–67.

    OpenUrlPubMed
15. 15.↵
    1. Clements P,
    2. Lachenbruch P,
    3. Siebold J,
    4. White B,
    5. Weiner S,
    6. Martin R,
    7. et al.

    Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis. J Rheumatol 1995;22:1281–5.

    OpenUrlPubMed
16. 16.↵
    1. Cutolo M,
    2. Sulli A,
    3. Secchi ME,
    4. Paolino S,
    5. Pizzorni C

    . Nailfold capillaroscopy is useful for the diagnosis and follow-up of autoimmune rheumatic diseases. A future tool for the analysis of microvascular heart involvement? Rheumatology 2006;45:43–6.

    OpenUrlCrossRefPubMed
17. 17.↵
    1. Rossi GP,
    2. Seccia TM,
    3. Barton M,
    4. Danser AHJ,
    5. de Leeuw PW,
    6. Dhaun N,
    7. et al.

    Endothelial factors in the pathogenesis and treatment of chronic kidney disease. Part I: General mechanisms: a joint consensus statement from the European Society of Hypertension Working Group on Endothelin and Endothelial Factors and The Japanese Society of Hypertension. J Hypertens 2018;36:451–61.

    OpenUrl
18. 18.↵
    1. Tang EH,
    2. Vanhoutte PM

    . Endothelial dysfunction: a strategic target in the treatment of hypertension? Pflugers Arch 2010;459:995–1004.

    OpenUrlCrossRefPubMed
19. 19.↵
    1. Hoi S,
    2. Takata T,
    3. Sugihara T,
    4. Ida A,
    5. Ogawa M,
    6. Mae Y,
    7. et al.

    Predictive value of cortical thickness measured by ultrasonography for renal impairment: a longitudinal study in chronic kidney disease. J Clin Med 2018;7:e527.

    OpenUrl
20. 20.↵
    1. Gigante A,
    2. Barbano B,
    3. Di Mario F,
    4. Rosato E,
    5. Simonelli M,
    6. Rocca AR,
    7. et al.

    Renal parenchymal resistance in patients with biopsy proven glomerulonephritis: correlation with histological findings. Int J Immunopathol Pharmacol 2016;29:469–74.

    OpenUrlCrossRefPubMed
21. 21.↵
    1. Geraci G,
    2. Mulè G,
    3. Geraci C,
    4. Mogavero M,
    5. D’Ignoto F,
    6. Morreale M,
    7. et al.

    Association of renal resistive index with aortic pulse wave velocity in hypertensive patients. Eur J Prev Cardiol 2015;22:415–22.

    OpenUrlCrossRefPubMed
22. 22.↵
    1. Mulè G,
    2. Geraci G,
    3. Geraci C,
    4. Morreale M,
    5. Cottone S

    . The renal resistive index: is it a misnomer? Intern Emerg Med 2015;10:889–91.

    OpenUrl
23. 23.↵
    1. Geraci G,
    2. Mulè G,
    3. Paladino G,
    4. Zammuto MM,
    5. Castiglia A,
    6. Scaduto E,
    7. et al.

    Relationship between kidney findings and systemic vascular damage in elderly hypertensive patients without overt cardiovascular disease. J Clin Hypertens 2017;19:1339–47.

    OpenUrl
24. 24.↵
    1. Toledo C,
    2. Thomas G,
    3. Schold JD,
    4. Arrigain S,
    5. Gornik HL,
    6. Nally JV,
    7. et al.

    Renal resistive index and mortality in chronic kidney disease. Hypertension 2015;66:382–8.

    OpenUrl
25. 25.↵
    1. Timár O,
    2. Soltész P,
    3. Szamosi S,
    4. Dér H,
    5. Szántó S,
    6. Szekanecz Z,
    7. et al.

    Increased arterial stiffness as the marker of vascular involvement in systemic sclerosis. J Rheumatol 2008;35:1329–33.

    OpenUrlAbstract/FREE Full Text
26. 26.↵
    1. Gigante A,
    2. Navarini L,
    3. Margiotta D,
    4. Amoroso A,
    5. Barbano B,
    6. Cianci R,
    7. et al.

    Angiogenic and angiostatic factors in renal scleroderma-associated vasculopathy. Microvasc Res 2017;114:41–5.

    OpenUrl
27. 27.↵
    1. Marek-Trzonkowska N,
    2. Kwieczyńska A,
    3. Reiwer-Gostomska M,
    4. Koliński T,
    5. Molisz A,
    6. Siebert J

    . Arterial hypertension is characterized by imbalance of pro-angiogenic versus anti-angiogenic factors. PLoS One 2015;10:e0126190.

    OpenUrlCrossRefPubMed
28. 28.↵
    1. Steen VD

    . Kidney involvement in systemic sclerosis. Presse Med 2014;43:e305–14.

    OpenUrl
29. 29.↵
    1. Sugiura T,
    2. Nakamori A,
    3. Wada A,
    4. Fukuhara Y

    . Evaluation of tubulointerstitial injury by Doppler ultrasonography in glomerular diseases. Clin Nephrol 2004;61:119–26.

    OpenUrlCrossRefPubMed
30. 30.↵
    1. Trostle DC,
    2. Bedetti CD,
    3. Steen VD,
    4. Al-Sabbagh MR,
    5. Zee B,
    6. Medsger TA Jr

    . Renal vascular histology and morphometry in systemic sclerosis. A case-control autopsy study. Arthritis Rheum 1988;31:393–400.

    OpenUrlCrossRefPubMed
31. 31.↵
    1. Sweiss NJ,
    2. Hushaw L,
    3. Thenappan T,
    4. Sawaqed R,
    5. Machado RF,
    6. Patel AR,
    7. et al.

    Diagnosis and management of pulmonary hypertension in systemic sclerosis. Curr Rheumatol Rep 2010;12:8–18.

    OpenUrlCrossRefPubMed
32. 32.↵
    1. Reem HA,
    2. Hania SZ,
    3. Amr A

    . Renal disease in systemic sclerosis with normal serum creatinine. Clin Rheumatol 2010;29:729–37.

    OpenUrlCrossRefPubMed